Medicines, Ema: the highlights of the last meeting of the Risk Assessment Committee

Rome, 18 January – Prac, the EMA Risk Assessment Committee, at its last meeting from 10 to 13 January published a series of recommendations and indications which were immediately sent to national regulators and the general public. We mention the summary, as suggested by AIFA on its foundation’s website.

Vaxzevria and COVID-19 Janssen vaccine: information on very rare cases of transverse myelitis